Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Research Solutions Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Research Solutions hat ein Gesamteigenkapital von $14.1M und eine Gesamtverschuldung von $0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $40.8M bzw. $26.7M.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$4.22m
Eigenkapital	US$14.13m
Gesamtverbindlichkeiten	US$26.67m
Gesamtvermögen	US$40.80m

Jüngste Berichte zur Finanzlage

We're Not Worried About Research Solutions' (NASDAQ:RSSS) Cash Burn

Dec 16

Companies Like Research Solutions (NASDAQ:RSSS) Can Afford To Invest In Growth

Jun 14

Recent updates

Take Care Before Diving Into The Deep End On Research Solutions, Inc. (NASDAQ:RSSS)

Mar 14

Artko Capital - Research Solutions: A Tumultuous Year But Outlook And Growth Look Excellent

Mar 07

Research Solutions, Inc. (NASDAQ:RSSS) Shares Could Be 46% Below Their Intrinsic Value Estimate

Sep 18

The Research Solutions (NASDAQ:RSSS) Share Price Is Up 402% And Shareholders Are Delighted

Feb 12

Our View On Research Solutions' (NASDAQ:RSSS) CEO Pay

Dec 21

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: RSSSDie kurzfristigen Aktiva des Unternehmens ($13.2M) decken seine kurzfristigen Passiva ($17.9M) nicht.

Langfristige Verbindlichkeiten: RSSSDie kurzfristigen Vermögenswerte des Unternehmens ($13.2M) übersteigen seine langfristigen Verbindlichkeiten ($8.8M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: RSSS ist schuldenfrei.

Schulden abbauen: RSSS hatte vor 5 Jahren keine Schulden.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: Obwohl RSSS unrentabel ist, verfügt es über eine ausreichende Cash-Runway für mehr als 3 Jahre, wenn es seinen derzeitigen positiven freier Cashflow beibehält.

Vorhersage Cash Runway: RSSS ist unrentabel, verfügt aber über eine ausreichende Liquiditätsreserve für mehr als drei Jahre, da der freie Cashflow positiv ist und um 18.7 % pro Jahr wächst.

Research Solutions Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

We're Not Worried About Research Solutions' (NASDAQ:RSSS) Cash Burn

Companies Like Research Solutions (NASDAQ:RSSS) Can Afford To Invest In Growth

Recent updates

Third quarter 2024 earnings released: EPS: US$0.003 (vs US$0.009 in 3Q 2023)

Research Solutions, Inc. to Report Q3, 2024 Results on May 09, 2024

Insider recently sold US$199k worth of stock

Take Care Before Diving Into The Deep End On Research Solutions, Inc. (NASDAQ:RSSS)

Artko Capital - Research Solutions: A Tumultuous Year But Outlook And Growth Look Excellent

Research Solutions Launches AI Platform to Automatically Create Technology Landscape Reports

New minor risk - Profitability

Now 22% undervalued

Second quarter 2024 earnings released: US$0.002 loss per share (vs US$0.01 loss in 2Q 2023)

Research Solutions, Inc. to Report Q2, 2024 Results on Feb 08, 2024

Insider recently sold US$56k worth of stock

Insider recently sold US$254k worth of stock

Insider recently sold US$184k worth of stock

Research Solutions, Inc. Approves Election of Kenneth L. Gayron to Board of Directors

Research Solutions, Inc. (NasdaqCM:RSSS) entered into an agreement to acquire Scite, Inc. for $14.8 million.

Research Solutions, Inc. (NasdaqCM:RSSS) entered into an agreement to acquire Scite, Inc. for $14.8 million.

First quarter 2024 earnings released: US$0.037 loss per share (vs US$0.008 profit in 1Q 2023)

Research Solutions, Inc. to Report Q1, 2024 Results on Nov 09, 2023

Research Solutions, Inc., Annual General Meeting, Nov 14, 2023

Research Solutions, Inc. Announces Resignation of Peter Derycz from Board of Directors

Research Solutions, Inc. (NASDAQ:RSSS) Shares Could Be 46% Below Their Intrinsic Value Estimate

Full year 2023 earnings: EPS exceeds analyst expectations

Research Solutions, Inc. to Report Q4, 2023 Results on Sep 14, 2023

Research Solutions, Inc. Announces Resignation of Eugene Robin as a Member of the Board of Directors

Research Solutions, Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter and Full Year Fiscal 2023

Bristol Capital Advisors Discloses its Views on Research Solutions

Research Solutions, Inc. (NasdaqCM:RSSS) acquired Resolute Innovation, Inc.

Third quarter 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Research Solutions, Inc. to Report Q2, 2023 Results on Feb 09, 2023

Independent Director exercised options to buy US$101k worth of stock.

We're Not Worried About Research Solutions' (NASDAQ:RSSS) Cash Burn

First quarter 2023 earnings released: EPS: US$0.008 (vs US$0.014 loss in 1Q 2022)

Forecast to breakeven in 2024

Research Solutions, Inc. to Report Q1, 2023 Results on Nov 10, 2022

Research Solutions Launches Curedatis, a Rapid Literature Review Platform for the Life Sciences Industry

Research Solutions, Inc., Annual General Meeting, Nov 17, 2022

Research Solutions, Inc. (NasdaqCM:RSSS) agreed to acquire Customer Contracts for AutoDoc Service of FIZ Karlsruhe from Fiz Karlsruhe - Leibniz-Institut FÜR Informationsinfrastruktur Gmbh.

Full year 2022 earnings: EPS exceeds analyst expectations

Research Solutions reports Q4 results

Research Solutions, Inc. to Report Q4, 2022 Results on Sep 22, 2022

Companies Like Research Solutions (NASDAQ:RSSS) Can Afford To Invest In Growth

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Research Solutions, Inc. Announces the Appointed of Barbara J. Cooperman to the Board of Directors

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Research Solutions Launches Automated Scholarly Literature Access Platform for Academic Institutions

First quarter 2022 earnings released: US$0.014 loss per share (vs US$0.001 profit in 1Q 2021)

Full year 2021 earnings released: US$0.011 loss per share (vs US$0.031 loss in FY 2020)

Research Solutions, Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ended June 30, 2021

Research Solutions, Inc. Unveils Article Galaxy Version 3.0 - in A Time When Rapid Scientific Research Is Crucial

Chief Technology Officer recently sold US$89k worth of stock

Independent Director has left the company

Independent Director exercised options to buy US$151k worth of stock.

New 90-day low: US$2.14

Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.028 loss in 2Q 2020)

The Research Solutions (NASDAQ:RSSS) Share Price Is Up 402% And Shareholders Are Delighted

Research Solutions, Inc. to Report Q2, 2021 Results on Feb 11, 2021

New 90-day high: US$2.46

Our View On Research Solutions' (NASDAQ:RSSS) CEO Pay

First quarter 2021 earnings released: EPS US$0.001

Research Solutions, Inc. to Report Q1, 2021 Results on Nov 12, 2020

New 90-day low: US$2.23

Research Solutions Partners with BIO Business Solutions to Bring One-Click Scientific Literature Access to the Biotech Industry

Full year earnings released - US$0.031 loss per share

Research Solutions, Inc. to Report Q4, 2020 Results on Sep 24, 2020

New 90-day low: US$2.29

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen